Patent · US Active

Compositions and methods for cardiac regeneration

US12128136B2 · kind B2 · utility

0Cited by
0References
18Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 2, 2018
Grant dateOct 29, 2024
Priority date
Expiry dateApr 2, 2038

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P9/04
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present disclosure provides microRNA-based therapies using a hydrogel delivery system that provides regenerative approach to myocardial infarction by targeting cardiomyocytes. The hydrogel provides for local and sustained cardiac delivery of microRNAs, such miR-302 mimics that can be used to promote cardiomyocyte proliferation. Also provided are compositions suitable for local and sustained release and methods for intramyocardial gel delivery of a miRNA oligonucleotide.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.